<i>Letter to the Editor:</i> A Favorable Benefit-Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment. | Hum Gene Ther;34(7-8): 339-340, 2023 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Letter to the Editor: A Favorable Benefit-Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment.

Qin, Albert.

Affiliation

Qin A; Medical Research and Clinical Operations, PharmaEssentia Corporation, Taipei, Taiwan.

Hum Gene Ther ; 34(7-8): 339-340, 2023 04.

Article in En | MEDLINE | ID: mdl-36860197

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenoviridae / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Hum Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenoviridae / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Hum Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: